The Role of Cardiovascular Magnetic Resonance in the Evaluation of Valve Disease

Progress in Cardiovascular Diseases

Volumn 54, Issue 3, 2011, Pages 276-286

  Karamitsos, Theodoros D ^a   Myerson, Saul G ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Cardiovascular magnetic resonance; Flow quantification; Phase contrast velocity mapping; Regurgitation; Stenosis

Indexed keywords

GADOLINIUM;

AORTA STENOSIS; AORTA VALVE REGURGITATION; ARTICLE; BLOOD FLOW VELOCITY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE SEVERITY; HEART ARRHYTHMIA; HEART HEMODYNAMICS; HEART LEFT VENTRICLE MASS; HEART MUSCLE BLOOD FLOW; HEART MUSCLE FIBROSIS; HEART VALVE PROSTHESIS; HEART VENTRICLE FUNCTION; HEART VENTRICLE VOLUME; HEART VOLUME; HUMAN; IMAGE ANALYSIS; IMAGE QUALITY; MITRAL VALVE REGURGITATION; MITRAL VALVE STENOSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PULMONARY VALVE INSUFFICIENCY; PULMONARY VALVE REPLACEMENT; PULMONARY VALVE STENOSIS; REPRODUCIBILITY; TREATMENT INDICATION; TRICUSPID VALVE REGURGITATION; TRICUSPID VALVE STENOSIS; VALVULAR HEART DISEASE;

HEART VALVE DISEASES; HEART VALVE PROSTHESIS; HEART VALVE PROSTHESIS IMPLANTATION; HEART VALVES; HUMANS; MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE OF TESTS; PROGNOSIS; SEVERITY OF ILLNESS INDEX;

EID: 80054781135     PISSN: 00330620     EISSN: 18731740     Source Type: Journal    
DOI: 10.1016/j.pcad.2011.08.005     Document Type: Article

References (65)

1. Douglas P.S., Garcia M.J., Haines D.E., et al. ACCF/ASE/AHA/ASNC/HFSA/HRS/SCAI/SCCM/SCCT/SCMR 2011 Appropriate Use Criteria for Echocardiography. A report of the American College of Cardiology Foundation Appropriate Use Criteria Task Force, American Society of Echocardiography, American Heart Association, American Society of Nuclear Cardiology, Heart Failure Society of America, Heart Rhythm Society, Society for Cardiovascular Angiography and Interventions, Society of Critical Care Medicine, Society of Cardiovascular Computed Tomography, and Society for Cardiovascular Magnetic Resonance Endorsed by the American College of Chest Physicians. J Am Coll Cardiol 2011, 57:1126-1166.
2. Karamitsos T.D., Francis J.M., Myerson S., et al. The role of cardiovascular magnetic resonance imaging in heart failure. J Am Coll Cardiol 2009, 54:1407-1424.
3. Westermann Y., Geigenmuller A., Elgeti T., et al. Planimetry of the aortic valve orifice area: comparison of multislice spiral computed tomography and magnetic resonance imaging. Eur J Radiol 2011, 77:426-435.
4. Sachdev M., Peterson G.E., Jollis J.G. Imaging techniques for diagnosis of infective endocarditis. Cardiol Clin 2003, 21:185-195.
5. Evans A.J., Blinder R.A., Herfkens R.J., et al. Effects of turbulence on signal intensity in gradient echo images. Invest Radiol 1988, 23:512-518.
6. Krombach G.A., Kuhl H., Bucker A., et al. Cine MR imaging of heart valve dysfunction with segmented true fast imaging with steady state free precession. J Magn Reson Imaging 2004, 19:59-67.
7. Bellenger N.G., Burgess M.I., Ray S.G., et al. Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?. Eur Heart J 2000, 21:1387-1396.
8. Myerson S.G., Bellenger N.G., Pennell D.J. Assessment of left ventricular mass by cardiovascular magnetic resonance. Hypertension 2002, 39:750-755.
9. Koch J.A., Poll L.W., Godehardt E., et al. Right and left ventricular volume measurements in an animal heart model in vitro: first experiences with cardiac MRI at 1.0 T. Eur Radiol 2000, 10:455-458.
10. Walsh T.F., Hundley W.G. Assessment of ventricular function with cardiovascular magnetic resonance. Magn Reson Imaging Clin N Am 2007, 15:487-504. v.
11. Bonow R.O., Carabello B.A., Chatterjee K., et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing Committee to Revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. J Am Coll Cardiol 2006, 48:e1-e148.
12. Globits S., Frank H., Mayr H., et al. Quantitative assessment of aortic regurgitation by magnetic resonance imaging. Eur Heart J 1992, 13:78-83.
13. Myerson S.G., Montgomery H.E., World M.J., et al. Left ventricular mass: reliability of M-mode and 2-dimensional echocardiographic formulas. Hypertension 2002, 40:673-678.
14. Grothues F., Smith G.C., Moon J.C., et al. Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy. Am J Cardiol 2002, 90:29-34.
15. Cheitlin M.D., Armstrong W.F., Aurigemma G.P., et al. ACC/AHA/ASE 2003 Guideline Update for the Clinical Application of Echocardiography: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). J Am Soc Echocardiogr 2003, 16:1091-1110.
16. Gatehouse P.D., Keegan J., Crowe L.A., et al. Applications of phase-contrast flow and velocity imaging in cardiovascular MRI. Eur Radiol 2005, 15:2172-2184.
17. Kilner P.J., Gatehouse P.D., Firmin D.N. Flow measurement by magnetic resonance: a unique asset worth optimising. J Cardiovasc Magn Reson 2007, 9:723-728.
18. Chatzimavroudis G.P., Oshinski J.N., Franch R.H., et al. Quantification of the aortic regurgitant volume with magnetic resonance phase velocity mapping: a clinical investigation of the importance of imaging slice location. J Heart Valve Dis 1998, 7:94-101.
19. Hundley W.G., Li H.F., Hillis L.D., et al. Quantitation of cardiac output with velocity-encoded, phase-difference magnetic resonance imaging. Am J Cardiol 1995, 75:1250-1255.
20. Sondergaard L., Lindvig K., Hildebrandt P., et al. Quantification of aortic regurgitation by magnetic resonance velocity mapping. Am Heart J 1993, 125:1081-1090.
21. Sondergaard L., Thomsen C., Stahlberg F., et al. Mitral and aortic valvular flow: quantification with MR phase mapping. J Magn Reson Imaging 1992, 2:295-302.
22. Firmin D.N., Nayler G.L., Kilner P.J., et al. The application of phase shifts in NMR for flow measurement. Magn Reson Med 1990, 14:230-241.
23. O'Brien K.R., Cowan B.R., Jain M., et al. MRI phase contrast velocity and flow errors in turbulent stenotic jets. J Magn Reson Imaging 2008, 28:210-218.
24. Karamitsos T.D., Neubauer S. Cardiovascular magnetic resonance in heart failure. Curr Cardiol Rep 2011, 13:210-219.
25. Kramer C.M., Barkhausen J., Flamm S.D., et al. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008, 10:35.
26. John A.S., Dill T., Brandt R.R., et al. Magnetic resonance to assess the aortic valve area in aortic stenosis: how does it compare to current diagnostic standards?. J Am Coll Cardiol 2003, 42:519-526.
27. Tanaka K., Makaryus A.N., Wolff S.D. Correlation of aortic valve area obtained by the velocity-encoded phase contrast continuity method to direct planimetry using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2007, 9:799-805.
28. Garcia J., Kadem L., Larose E., et al. Comparison between cardiovascular magnetic resonance and transthoracic doppler echocardiography for the estimation of effective orifice area in aortic stenosis. J Cardiovasc Magn Reson 2011, 13:25.
29. Kilner P.J., Manzara C.C., Mohiaddin R.H., et al. Magnetic resonance jet velocity mapping in mitral and aortic valve stenosis. Circulation 1993, 87:1239-1248.
30. Sondergaard L., Hildebrandt P., Lindvig K., et al. Valve area and cardiac output in aortic stenosis: quantification by magnetic resonance velocity mapping. Am Heart J 1993, 126:1156-1164.
31. Francois C.J., Carr J.C. MRI of the thoracic aorta. Magn Reson Imaging Clin N Am 2007, 15:639-651. vii.
32. Debl K., Djavidani B., Buchner S., et al. Delayed hyperenhancement in magnetic resonance imaging of left ventricular hypertrophy caused by aortic stenosis and hypertrophic cardiomyopathy: visualisation of focal fibrosis. Heart 2006, 92:1447-1451.
33. Hein S., Arnon E., Kostin S., et al. Progression from compensated hypertrophy to failure in the pressure-overloaded human heart: structural deterioration and compensatory mechanisms. Circulation 2003, 107:984-991.
34. Dweck M.R., Joshi S., Murigu T., et al. Mid-wall fibrosis is an independent predictor of mortality in patients with aortic stenosis (abstr). Heart 2011, 97:A94.
35. Dulce M.C., Mostbeck G.H., O'Sullivan M., et al. Severity of aortic regurgitation: interstudy reproducibility of measurements with velocity-encoded cine MR imaging. Radiology 1992, 185:235-240.
36. Honda N., Machida K., Hashimoto M., et al. Aortic regurgitation: quantitation with MR imaging velocity mapping. Radiology 1993, 186:189-194.
37. Myerson S.G., D'Arcy J., Mohiaddin R., et al. Aortic regurgitation quantification with cardiovascular magnetic resonance predicts clinical outcome (abstr). Heart 2011, 97:A93-A94.
38. Bonow R.O. Aortic regurgitation: time to reassess timing of valve replacement?. JACC Cardiovasc Imaging 2011, 4:231-233.
39. Underwood S.R., Klipstein R.H., Firmin D.N., et al. Magnetic resonance assessment of aortic and mitral regurgitation. Br Heart J 1986, 56:455-462.
40. Djavidani B., Debl K., Lenhart M., et al. Planimetry of mitral valve stenosis by magnetic resonance imaging. J Am Coll Cardiol 2005, 45:2048-2053.
41. Lin S.J., Brown P.A., Watkins M.P., et al. Quantification of stenotic mitral valve area with magnetic resonance imaging and comparison with Doppler ultrasound. J Am Coll Cardiol 2004, 44:133-137.
42. Myerson S.G., Francis J.M., Neubauer S. Direct and indirect quantification of mitral regurgitation with cardiovascular magnetic resonance, and the effect of heart rate variability. MAGMA 2010, 23:243-249.
43. Chan K.M., Wage R., Symmonds K., et al. Towards comprehensive assessment of mitral regurgitation using cardiovascular magnetic resonance. J Cardiovasc Magn Reson 2008, 10:61.
44. Fujita N., Chazouilleres A.F., Hartiala J.J., et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 1994, 23:951-958.
45. Gelfand E.V., Hughes S., Hauser T.H., et al. Severity of mitral and aortic regurgitation as assessed by cardiovascular magnetic resonance: optimizing correlation with Doppler echocardiography. J Cardiovasc Magn Reson 2006, 8:503-507.
46. Kon M.W., Myerson S.G., Moat N.E., et al. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 2004, 13:600-607.
47. D'Arcy J., Christiansen J.P., Mohiaddin R., et al. Prediction of clinical outcome in asymptomatic mitral regurgitation using CMR (abstr) 2011.
48. Buchner S., Debl K., Poschenrieder F., et al. Cardiovascular magnetic resonance for direct assessment of anatomic regurgitant orifice in mitral regurgitation. Circ Cardiovasc Imaging 2008, 1:148-155.
49. Li W., Davlouros P.A., Kilner P.J., et al. Doppler-echocardiographic assessment of pulmonary regurgitation in adults with repaired tetralogy of Fallot: comparison with cardiovascular magnetic resonance imaging. Am Heart J 2004, 147:165-172.
50. Rebergen S.A., Chin J.G., Ottenkamp J., et al. Pulmonary regurgitation in the late postoperative follow-up of tetralogy of Fallot. Volumetric quantitation by nuclear magnetic resonance velocity mapping. Circulation 1993, 88:2257-2266.
51. Ammash N.M., Dearani J.A., Burkhart H.M., et al. Pulmonary regurgitation after tetralogy of Fallot repair: clinical features, sequelae, and timing of pulmonary valve replacement. Congenit Heart Dis 2007, 2:386-403.
52. Geva T. Indications and timing of pulmonary valve replacement after tetralogy of Fallot repair. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu 2006, 11-22.
53. Oosterhof T., van Straten A., Vliegen H.W., et al. Preoperative thresholds for pulmonary valve replacement in patients with corrected tetralogy of Fallot using cardiovascular magnetic resonance. Circulation 2007, 116:545-551.
54. Lurz P., Coats L., Khambadkone S., et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation 2008, 117:1964-1972.
55. Schievano S., Coats L., Migliavacca F., et al. Variations in right ventricular outflow tract morphology following repair of congenital heart disease: implications for percutaneous pulmonary valve implantation. J Cardiovasc Magn Reson 2007, 9:687-695.
56. Kuehne T., Saeed M., Reddy G., et al. Sequential magnetic resonance monitoring of pulmonary flow with endovascular stents placed across the pulmonary valve in growing Swine. Circulation 2001, 104:2363-2368.
57. Mahle W.T., Parks W.J., Fyfe D.A., et al. Tricuspid regurgitation in patients with repaired Tetralogy of Fallot and its relation to right ventricular dilatation. Am J Cardiol 2003, 92:643-645.
58. Choi Y.H., Park J.H., Choe Y.H., et al. MR imaging of Ebstein's anomaly of the tricuspid valve. AJR Am J Roentgenol 1994, 163:539-543.
59. Eustace S., Kruskal J.B., Hartnell G.G. Ebstein's anomaly presenting in adulthood: the role of cine magnetic resonance imaging in diagnosis. Clin Radiol 1994, 49:690-692.
60. Shellock F.G. MR imaging of metallic implants and materials: a compilation of the literature. AJR Am J Roentgenol 1988, 151:811-814.
61. Shellock F. Reference manual for magnetic resonance safety, implants and devices: 2011 edition 2011, Biomedical Research Publishing Group, Los Angeles.
62. Botnar R., Nagel E., Scheidegger M.B., et al. Assessment of prosthetic aortic valve performance by magnetic resonance velocity imaging. Magma 2000, 10:18-26.
63. Hasenkam J.M., Ringgaard S., Houlind K., et al. Prosthetic heart valve evaluation by magnetic resonance imaging. Eur J Cardiothorac Surg 1999, 16:300-305.
64. von Knobelsdorff-Brenkenhoff F., Rudolph A., Wassmuth R., et al. Feasibility of cardiovascular magnetic resonance to assess the orifice area of aortic bioprostheses. Circ Cardiovasc Imaging 2009, 2:397-404. 2 p following.
65. Reiter G., Reiter U., Kovacs G., et al. Magnetic resonance?derived 3-dimensional blood flow patterns in the main pulmonary artery as a marker of pulmonary hypertension and a measure of elevated mean pulmonary arterial pressure. Circ Cardiovasc Imaging 2008, 1:23-30.